Trust Investment Advisors Buys 13,605 Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

Trust Investment Advisors grew its position in Celsius Holdings, Inc. (NASDAQ:CELH) by 595.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 15,891 shares of the company’s stock after acquiring an additional 13,605 shares during the period. Trust Investment Advisors’ holdings in Celsius were worth $866,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Envestnet Asset Management Inc. boosted its stake in shares of Celsius by 20.9% during the first quarter. Envestnet Asset Management Inc. now owns 5,908 shares of the company’s stock valued at $326,000 after purchasing an additional 1,023 shares in the last quarter. JPMorgan Chase & Co. boosted its position in Celsius by 8.5% during the 1st quarter. JPMorgan Chase & Co. now owns 54,953 shares of the company’s stock worth $3,033,000 after buying an additional 4,285 shares during the period. Raymond James Financial Services Advisors Inc. boosted its position in Celsius by 4.3% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 9,583 shares of the company’s stock worth $529,000 after buying an additional 398 shares during the period. Bank of New York Mellon Corp grew its holdings in Celsius by 1.9% during the 1st quarter. Bank of New York Mellon Corp now owns 394,530 shares of the company’s stock worth $21,771,000 after acquiring an additional 7,411 shares during the last quarter. Finally, MetLife Investment Management LLC raised its stake in shares of Celsius by 53.1% during the first quarter. MetLife Investment Management LLC now owns 28,662 shares of the company’s stock valued at $1,582,000 after acquiring an additional 9,946 shares during the last quarter. 60.95% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CELH has been the topic of several analyst reports. Maxim Group boosted their price objective on shares of Celsius from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Wedbush raised their price objective on Celsius from $75.00 to $90.00 and gave the stock an “outperform” rating in a research report on Monday, March 4th. Stifel Nicolaus increased their target price on shares of Celsius from $67.00 to $90.00 and gave the company a “buy” rating in a research report on Friday, March 1st. Stifel Europe raised their price target on shares of Celsius from $90.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, March 18th. Finally, Roth Mkm upped their price objective on shares of Celsius from $90.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, March 14th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, Celsius has an average rating of “Moderate Buy” and an average price target of $85.10.

Insider Transactions at Celsius

In related news, major shareholder Dean Desantis sold 100,000 shares of the stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total transaction of $9,575,000.00. Following the completion of the transaction, the insider now owns 219,257 shares in the company, valued at $20,993,857.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. In related news, major shareholder Dean Desantis sold 100,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $95.75, for a total value of $9,575,000.00. Following the transaction, the insider now owns 219,257 shares in the company, valued at $20,993,857.75. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Caroline S. Levy sold 20,000 shares of the stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total value of $1,895,400.00. Following the transaction, the director now directly owns 37,891 shares of the company’s stock, valued at $3,590,930.07. The disclosure for this sale can be found here. Insiders have sold 1,094,783 shares of company stock worth $62,679,671 in the last ninety days. Company insiders own 2.70% of the company’s stock.

Celsius Trading Down 1.4 %

Shares of CELH traded down $1.00 during trading hours on Thursday, reaching $69.97. 3,289,117 shares of the stock traded hands, compared to its average volume of 4,775,403. The company has a market cap of $16.16 billion, a price-to-earnings ratio of 91.77, a PEG ratio of 2.12 and a beta of 1.86. Celsius Holdings, Inc. has a 52 week low of $28.10 and a 52 week high of $99.62. The stock has a fifty day simple moving average of $78.36 and a 200 day simple moving average of $64.03.

Celsius (NASDAQ:CELH) last released its earnings results on Thursday, February 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.01. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The company had revenue of $347.44 million during the quarter, compared to analyst estimates of $326.77 million. During the same period in the prior year, the company posted $0.01 earnings per share. Celsius’s quarterly revenue was up 95.2% on a year-over-year basis. Analysts predict that Celsius Holdings, Inc. will post 1.09 earnings per share for the current fiscal year.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.